SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as the community discusses the implications of the company's recent Phase III trial failure for its Alzheimer's drug, with some investors expressing disappointment while others see it as an opportunity to buy. Despite the setback, there is optimism surrounding Novo Nordisk's position in the weight loss market, particularly with the potential upcoming approval of its oral Wegovy pill and comparison of CagriSema vs Zepbound study results.

Pony.ai, Inc. develops artificial intelligence-based robot designed for autonomous driving. The firm's software algorithms and infrastructure enables a vehicle to perceive its surroundings, predict what others will do, and maneuver itself accordingly. The company was founded by Jun Peng and Tian Cheng Lou in November 4, 2016 and is headquartered in Guangzhou, China.

Pony AI Inc. - ADR

Pony AI Inc

Pony AI is trending due to news of expanded robotaxi operations and partnerships, including a recent permit in Shanghai. The community is weighing the company's growth prospects against its financial performance, especially regarding profitability targets. Broader discussions involve comparing Pony AI to competitors in the autonomous driving space and assessing the impact of these developments on its market position.

Diginex Ltd. (Hong Kong) is a blockchain financial services and technology company. Its products include diginexESG, diginexLUMEN, diginexAPPRISE, diginexLUMEN Pro, and CSRD framework. The company was founded by Miles Christian Pelham on May 15, 2020 and is headquartered in London, the United Kingdom.

Diginex Ltd.

DGNX is trending due to its recent acquisition of The Remedy Project, sparking discussions about the company's expansion into human-rights remediation. The community is also actively analyzing potential trading strategies based on historical patterns of similar stocks. Options traders are closely monitoring put contracts, anticipating potential downside amidst the volatility.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide is trending due to strong Q3 2025 earnings, highlighted by a 144.3% YoY revenue increase and significant growth in robotaxi revenue, with community members noting global expansion and regulatory milestones in the UAE and Switzerland. Investors are focused on WeRide's progress toward deploying hundreds of thousands of robotaxis by 2030 and its partnerships with companies like Bosch, Uber, and Grab. The conversation also includes comparisons to competitor Pony.ai, whose stock performance and institutional ownership are being weighed against WeRide's recent gains and expansion efforts.

Monad

Monad is trending as users discuss its upcoming launch and token distribution, particularly excitement around receiving tokens from the Coinbase presale. The community is actively speculating on potential price movements and strategies, with some comparing it to other recent launches. There's also discussion around the mainnet launch date.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending amid mixed sentiment, as discussions range from its ties to controversial figures to its evolving stance on cryptocurrency and potential competition with Bitcoin. The community is actively debating JPMorgan's investment strategies, alleged market manipulation, and the implications of its exploration of blockchain technology and stablecoins. Additionally, some traders are monitoring technical indicators to predict JPM's short-term price movements, while others are discussing potential investigations and regulatory scrutiny.

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.

Alvotech

Alvotech ($ALVO) is trending following the announcement of European approval for AVT03, a biosimilar to Prolia and Xgeva, used in bone disease treatment, sparking bullish sentiment. Despite some community concerns about cash flow and previous manufacturing setbacks, the biosimilar's approval and analyst upgrades are fueling optimism. Discussions center on the company's potential in the biosimilar market and strategic partnerships.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is trending as the stock price rises following news of its AI integration with Open AI, which is expected to enhance merchant and customer experiences, with some analysts predicting a significant price target increase. However, some community members are skeptical about the sustainability of Shopify's growth, citing competition and valuation concerns, while others point to the company's strong position in the e-commerce sector and potential for further gains.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi-Aventis ($SNY) is trending amid speculation surrounding potential acquisitions, particularly in the MASH and obesity spaces, with $ALT, $GUTS, and $IVA being mentioned as possible targets. Community discussions revolve around the company's pipeline expansion needs and potential partnerships, with some users highlighting data integrity concerns around one of the speculated targets. The broader context involves Sanofi's strategic moves to strengthen its immunology and vaccine portfolio.

mF International Ltd. is a holding company, which engages in the development and provision of financial trading solutions through its subsidiary. It offers real-time mission critical forex, bullion and commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company was founded by Tai Wai Lam and Chi Weng Tam on June 15, 2022, and is headquartered in Hong Kong.

mF International Ltd - Ordinary Shares - Class A

mF International Ltd

MFI is trending due to its recent $500M private placement aimed at building a Bitcoin Cash treasury, fueling speculation about a potential pivot into crypto equity. Community members are discussing the involvement of a Chinese billionaire and the possibility of MFI becoming a major player in the crypto space. The stock's volatile price action and small float are contributing to the heightened interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

September 23, 2025 08:00 ET &nbsp;| Source: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/en/search/organization/GraniteShares">GraniteShares</a>New York, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- GraniteShares, an ETF issuer specializing in high conviction ETFs, announced that it is launching two ETFs to add to its existing YieldBOOST lineup - the GraniteShares YieldBOOST MSTR ETF (MTYY) and the GraniteShares YieldBOOST PLTR ETF (PLYY).The GraniteShares YieldBOOST MSTR ETF (MTYY) is designed to generate income through options strategies linked to the 2x Long MSTR Daily ETF. To achieve this, MTYY sells put options on leveraged ETFs tied to MSTR.Similarly, the GraniteShares YieldBOOST PLTR ETF (PLYY) seeks to generate income from options strategies linked to the 2x Long PLTR Daily ETF. PLYY does so by selling put options on leveraged ETFs tied to PLTR.Key Details:<figure class="table" style="width:989.875px;"><table style="border:1pt solid black;"><tbody><tr><td style="border:1pt solid black;text-align:center;vertical-align:top;">Fund Name</td><td style="border:1pt solid black;text-align:center;vertical-align:top;">Ticker</td><td style="border:1pt solid black;text-align:center;vertical-align:top;">CUSIP</td></tr><tr><td style="border:1pt solid black;text-align:center;vertical-align:top;"><a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=Kzbrn0BoQh6z-XVbZOCzI_ohBFKPXhknOw2jRdcCOoxSHn_0HK4xTHkA9VOX2yGqHDsPioLcXW16UBYbRXgx0hFDzY0fXHFCq_e9F0X8My1mog-KFgssnfmAmKmsLaqfF8fzXXT25HMuAad5FjDT1z6szSxBvhfPS_sV1cyRzqE=">GraniteShares YieldBOOST MSTR ETF</a></td><td style="border:1pt solid black;text-align:center;vertical-align:top;"><a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=JpIYgc1fGxvATTmznQSHwYsSibwOitCpzMgDZCegOF7VMxwnwJFqb1TBBvJHrlUxQg5ZwqysnLSwQRfmGmLM3PXfzv5J-SOobxMymZORuTphcgEt_Q7dLpgJv1n4ebCx">MTYY</a></td><td style="border:1pt solid black;text-align:center;vertical-align:top;">38747R 280</td></tr><tr><td style="border:1pt solid black;text-align:center;vertical-align:top;"><a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=Kzbrn0BoQh6z-XVbZOCzI_ohBFKPXhknOw2jRdcCOoyaG9l5KAs8PfADzn0rfpJy42mBD2s3beBYvB6Cnc4SHgH-5vdjhsDuXnuiT_xSw37Mwb4m_dBTCQxMmN-bHppfto1yIUbaj1zK2nvyHhKOBY7clflzGDMTwqrnV6SbNMU=">GraniteShares YieldBOOST PLTR ETF</a></td><td style="border:1pt solid black;text-align:center;vertical-align:top;"><a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=Yw8nUnaD82RbOwikv4AA175QF1jXSTKI_KO-omuexeSJbd9oGPZBwv0PiJPcwZV1uCYWsxxggHZ-JWjcV073mEjYEV6aQ66o2UzJk03wnEiZXoUTuTkXXetPjea0lNjo">PLYY</a></td><td style="border:1pt solid black;text-align:center;vertical-align:top;">38747R 272</td></tr></tbody></table></figure> "We are excited to launch the newest additions to our YieldBOOST options income suite, which has grown over $532 million in AUM (as of 19th September 2025),” said Will Rhind, Founder and CEO of GraniteShares. “The GraniteShares YieldBOOST MSTR ETF (MTYY) and YieldBOOST PLTR ETF (PLYY) will seek to generate income from selling put options on their respective underlying leveraged ETFs.”For more information, please visit: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=xPQn6wcgir3FhzJsYoWXNiAlXJCvVIAV1FMvIEOhak4dHvP5gudBPCFloMyWCVzk6KVkRyg2MBteJpNFfLcDmhuArB_AFPz3T98Ap5RMJShlzicOoj5LnxzMTNwewOx7-XDNSKNZnGyrL6JUnasbwA==">www.graniteshares.com</a>.About GraniteShares:GraniteShares is an entrepreneurial ETF provider focused on high-conviction investment solutions. The firm offers a range of ETFs spanning leveraged, inverse, and high-yield strategies, empowering investors with differentiated tools for portfolio construction. Founded in 2016, GraniteShares has grown rapidly by delivering cutting-edge solutions tailored to modern market needs. For more information, visit&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=xPQn6wcgir3FhzJsYoWXNiAlXJCvVIAV1FMvIEOhak5F_1iiuOt7xH8LwcbNUXfM8A9vJ2EJpMAa-Jzu_2WbPXJWVkf8YvmuIymzcdvMVySGLguRfUJkB0tVStNoSUXxtNnGQUkjhykLaX52Lm1h3YhjP9FMJpIKflk0-rm8IOW1maYoWO9r9L4xS5rLNLlM5QFeVpgYizN9G5TCX91BNTeuxVBbvCbTHOptS0XofteZLPqWkb6D_Sre9PFtsCL3jl0t3lGbZofH8mtSRQn9jQ==">www.graniteshares.com</a>.Source: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=j5Y7epVKSejqIinmX_USsivavNQYyUi6DBzvDjGNwykJ7YQGRJZZtrHnwGIz66_2YEpiBBAA_kgp4X3OgdJmAvtPxz-D3QKwTGzo-EgEz57WTo859PI9R84pOC_g0kOQ">GraniteShares</a>1An option is a contract that gives the holder the right, but not the obligation, to buy or sell a specific asset at a predetermined price on or before a specified date. Options are a type of derivative, meaning their value is derived from the underlying asset. 2A put option is a contract that gives the buyer the right, but not the obligation, to sell an underlying asset at a specified price (the strike price) by or on a specific date (the expiration date).RISK FACTORS &amp; IMPORTANT INFORMATIONThe fund is newly launched and has risks associated with its limited operating history.Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus or summary prospectus with this and other information about the Funds, please call (844) 476 8747 or. Read the&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=3DwyH8XTSllCwFMihk6NwZJkmq5dFR5bUy09CNYO0CRKntb9K3npoQqoRjZ9J5Mi1WETkCs8j7RKh-3cAHA-iWohs1GXrKENXRbKEeGUme2-XMNpOydrA8g2iCyNfGqhBYBWjBgzf4b1f-02MMhRwp5RVjdntexO1gKX-P-pwN0=">prospectus</a>&nbsp;or summary prospectus carefully before investing.There is no guarantee that the Fund’s investment strategy will be properly implemented, and an investor may lose some or all of its investment.An Investment in the Fund is not an investment in the Underlying MSTR and PLTR ETFThe Fund’s strategy will cap its potential gain if the Underlying MSTR and PLTR ETF’s share increases in valuesThe Fund’s strategy is subject to all potential losses if the Underlying MSTR and PLTR ETF’s share decline, which may not be offset but the income received by the Fund,The Fund does not invest directly in the Underlying MSTR and PLTR ETF,Fund shareholders are not entitled to any distribution paid by Underlying MSTR and PLTR ETF.Shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from the returns.An investment in the Fund involves risk, including the possible loss of principal. The Fund is non-diversified and includes risks associated with the Fund concentrating its investments in a particular industry, sector, or geographic region which can result in increased volatility. The use of derivatives such as option contracts and swaps is subject to market risks that may cause their price to include Risk of the Underlying ETF, Derivatives Risk, A Risk, Put Writing Strategy Risk, Option Market Liquidity Risk. These and other risks can be found in the prospectus.This information is not an offer to sell or a solicitation of an offer to buy the shares of any Funds to any person in any jurisdiction in which an offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction. Please consult your tax advisor about the tax consequences of an investment in Fund shares, including the possible application of foreign, state, and local tax laws. You could lose money by investing in the ETFs. There can be no assurance that the investment objective of the Funds will be achieved. None of the Funds should be relied upon as a complete investment program.THE FUNDS ARE DISTRIBUTED BY ALPS DISTRIBUTORS, INC. GRANITESHARES IS NOT AFFILIATED WITH ALPS DISTRIBUTORS, INC.©2025 GraniteShares Inc. All rights reserved. GraniteShares, GraniteShares ETFs, and the GraniteShares logo are registered and unregistered trademarks of GraniteShares Inc., in the United States and elsewhere. All other marks are the property of their respective owners.Media Contact: GraniteShares Inc. Attn: Media Relations 222 Broadway, 21st Floor New York, NY 10038 844-476-8747 <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=jC9TWHU4NdxfubLW3WwdTjYY1D5dzb8L2viwqCw19gYCzSUfJBtE91VsZU-Hda047KLVrZFITniwcpAYiTiJVZpFG1u2L4ZjKE8k3p6MESI=">info@graniteshares.com</a>Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

GraniteShares launches new YieldBOOST ETFs on MSTR (MTYY) and PLTR (PLYY).

GraniteShares launched two new ETFs, MTYY and PLYY, to its YieldBOOST lineup. They generate income by selling put options on leveraged ETFs tied to MSTR and PLTR.

PLYY
GraniteShares YieldBOOST PLTR ETF

Feed

News

Sentiment

Fundamentals

Info

Latest PLYY News

PLYYGraniteShares YieldBOOST PLTR ETF